Claude M. Schwizgebel is a seasoned finance executive with over 30 years of experience in the pharmaceutical and vaccine industries, currently serving as the Sr. Director of Finance and Head of Financial Planning & Analysis for Takeda’s Global Vaccine Business Unit. Claude has led critical financial strategy initiatives across research, development, and commercialization, contributing to global product launches like Qdenga®. They have a proven track record of driving performance, investment decisions, and patient-focused growth while excelling in complex, multicultural environments. Claude's expertise includes financial planning and analysis, controlling, and strategic business partnering, underscored by a recognized ability to translate financial insights into actionable strategies.
Location
Liestal, Switzerland
This person is not in any teams
This person is not in any offices